Back to News
Market Impact: 0.12
WELL Health Announces WELLTRUST(TM) Surpasses 100,000 Patient Consents
Source: newsfilecorp.com
Healthcare & Biotech

WELLTRUST, a consented patient database for clinical-trial and research-study recruitment, surpassed 100,000 patient consents after launching in February 2026. The milestone expands the pool of patients who have agreed to be contacted for health-circumstance-matched research opportunities, though no financial impact or commercial metrics were disclosed.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.35
More News
- Stock Movers: Chime, Stryker, Compass Pathways (Podcast)
- Attacks Halt Saudi Energy Sites, Novartis Drops Most in 6 Years | The Opening Trade 9/8/2026
- Pharma major plummets over 10% after third trial disappointment in a week
- Kaplan Fox Continues to Alert Investors of Hims & Hers Health, Inc. (NYSE: HIMS) to a Class Action Deadline on November 2, 2026
- Stock Movers: SpaceX, Qualcomm, Roivant (Podcast)
- Novartis Stock Drops as Trial Failures Ripple Across Biotech Partners